Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on multi component reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110407739B details a high-yield, one-pot synthesis of diaryl-tetrahydropyridines. This method offers 100% atom economy and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN111909113A details a metal-free route to 2-substituted benzothiazoles using elemental sulfur, offering significant cost reduction and simplified supply chain management.
Patent CN101402582A reveals a novel one-step four-component reaction for high-purity pharmaceutical intermediates. This method significantly reduces cost and improves supply chain reliability.
Novel one-pot method for 9H-pyrido[2,3-b]indole compounds offering cost reduction in pharmaceutical manufacturing and high-purity intermediates.
Patent CN111423381B details a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering high purity and scalable manufacturing for pharma.
Novel Rh-catalyzed one-step synthesis of 1,2,5-polysubstituted imidazoles. High atom economy, scalable process for reliable pharmaceutical intermediate supply chain.
Patent CN112480015B details a Pd-catalyzed one-pot synthesis. Offers cost reduction in API manufacturing and high-purity pharmaceutical intermediates with scalable protocols.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Patent CN102060761B reveals a metal-free iodine-catalyzed route for quinoline derivatives, offering significant cost reduction and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN113372346B reveals a metal-free, room-temperature synthesis route for imidazo[1,2-a]pyridine derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN110746336B reveals a green, solvent-free iodine-catalyzed route for N-methyl-2-cyano-3-arylpyrrole intermediates, offering high atom efficiency and simplified purification for API manufacturing.
Patent CN104804002B reveals a one-pot copper-catalyzed route for 9H-pyrimido[4,5-b]indole compounds, offering cost-effective manufacturing and supply chain stability for pharmaceutical intermediates.
Patent CN108864110B reveals a novel organocatalytic route for anticancer naphthoquinopyrans, offering improved safety and scalability for pharmaceutical intermediate manufacturing.
Patent CN110483387B reveals efficient Cu-catalyzed route. High purity, scalable process for pharma intermediates reducing manufacturing complexity.
Patent CN115353511A details a safe, multicomponent palladium-catalyzed synthesis of carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and scalable production.
Patent CN121426725A reveals efficient palladium-catalyzed route. Delivers high-purity intermediates with streamlined supply chain and cost advantages.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Patent CN109053603A enables aqueous synthesis of triazoles. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Patent CN110483387B reveals a novel one-pot synthesis for 2,N,4,5,6-pentasubstituted nicotinamide derivatives, offering high yields and simplified purification for pharmaceutical intermediate manufacturing.